Announcements Trials

Browse Landscape

Phase

Status

Completed 17 Unknown 6 Withdrawn 4 Terminated 4 Active not recruiting 4 Recruiting 3 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Hepatitis 1 Colitis 1

Interventions

Carboplatin 127 Cisplatin 125 Drug Therapy 116 Bevacizumab 102 Capecitabine 100 Oxaliplatin 99 Radiotherapy 97 Gemcitabine 87 tislelizumab 86 Paclitaxel 86 Cyclophosphamide 85 pembrolizumab 77 Specimen Handling 77 toripalimab 70 Magnetic Resonance Spectroscopy 63 Injections 63 Fluorouracil 63 sintilimab 58 Surgical Procedures, Operative 58 anlotinib 53 Docetaxel 52 130-nm albumin-bound paclitaxel 51 fludarabine 47 Standard of Care 45 Pemetrexed 45 Immune Checkpoint Inhibitors 45 Blood Specimen Collection 43 venetoclax 42 Leucovorin 42 lenvatinib 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Infliximab × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡